The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients
2004 · Pharmacogenetics · 444 citations
https://doi.org/10.1097/00008571-200403000-00002
P
Pierre Wallemacq
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
350
Papers
10.6K
Citations
55
h-index
185
i10-index
Pierre Wallemacq is an academic researcher from Cliniques Universitaires Saint-Luc. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Pharmacological Effects and Toxicity Studies & Antibiotics Pharmacokinetics and Efficacy. The author has an h-index of 55, co-authored 298 publications.
Papers by this author
worksInsufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
2010 · Critical Care · 363 citations
https://doi.org/10.1186/cc9091
Therapeutic Drug Monitoring of Everolimus
2016 · Therapeutic Drug Monitoring · 131 citations
https://doi.org/10.1097/ftd.0000000000000260
The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium
2010 · BMC Geriatrics · 89 citations
https://doi.org/10.1186/1471-2318-10-39
A Simultaneous D‐Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation
2011 · The Journal of Clinical Pharmacology · 39 citations
https://doi.org/10.1177/0091270011423661
The glomerular filtration rate estimated by new and old equations as a predictor of important outcomes in elderly patients
2014 · BMC Medicine · 38 citations
https://doi.org/10.1186/1741-7015-12-27
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat